Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Csrnp2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSRNP2 mRNA | CTD | PMID:21570461 and PMID:24058054 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CSRNP2 mRNA | CTD | PMID:21179406 | 6-propyl-2-thiouracil | decreases expression | ISO | Csrnp2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of CSRNP2 mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CSRNP2 mRNA | CTD | PMID:21641981 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CSRNP2 mRNA | CTD | PMID:23724009 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of CSRNP2 mRNA | CTD | PMID:33212167 | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CSRNP2 mRNA | CTD | PMID:19162166 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CSRNP2 mRNA | CTD | PMID:21632981 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of CSRNP2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CSRNP2 5' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | Csrnp2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CSRNP2 mRNA | CTD | PMID:25181051 more ... | bisphenol A | affects methylation | ISO | Csrnp2 (Mus musculus) | 6480464 | bisphenol A affects the methylation of CSRNP2 promoter | CTD | PMID:27334623 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CSRNP2 mRNA | CTD | PMID:16002434 | choline | multiple interactions | ISO | Csrnp2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CSRNP2 gene | CTD | PMID:20938992 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of CSRNP2 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CSRNP2 mRNA | CTD | PMID:20106945 and PMID:25562108 | dimethylarsinic acid | multiple interactions | ISO | Csrnp2 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA | CTD | PMID:34876320 | disodium selenite | decreases expression | EXP | | 6480464 | Sodium Selenite results in decreased expression of CSRNP2 mRNA | CTD | PMID:18175754 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CSRNP2 mRNA | CTD | PMID:29803840 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA | CTD | PMID:19167446 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of CSRNP2 mRNA | CTD | PMID:23649840 | fenthion | decreases expression | ISO | Csrnp2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of CSRNP2 mRNA | CTD | PMID:34813904 | fipronil | decreases expression | ISO | Csrnp2 (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of CSRNP2 mRNA | CTD | PMID:34044035 | folic acid | multiple interactions | ISO | Csrnp2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CSRNP2 gene | CTD | PMID:20938992 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of CSRNP2 mRNA | CTD | PMID:23649840 | L-methionine | multiple interactions | ISO | Csrnp2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CSRNP2 gene | CTD | PMID:20938992 | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of CSRNP2 mRNA | CTD | PMID:33647349 | mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of CSRNP2 mRNA | CTD | PMID:19937285 | mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of CSRNP2 mRNA | CTD | PMID:19937285 | methidathion | decreases expression | ISO | Csrnp2 (Mus musculus) | 6480464 | methidathion results in decreased expression of CSRNP2 mRNA | CTD | PMID:34813904 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of CSRNP2 mRNA | CTD | PMID:23649840 | methylarsonic acid | multiple interactions | ISO | Csrnp2 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA | CTD | PMID:34876320 | mitoxantrone | affects response to substance | EXP | | 6480464 | CSRNP2 mRNA affects the susceptibility to Mitoxantrone | CTD | PMID:16044152 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of CSRNP2 mRNA | CTD | PMID:25583101 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CSRNP2 mRNA | CTD | PMID:21420995 more ... | paracetamol | increases expression | ISO | Csrnp2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CSRNP2 mRNA | CTD | PMID:33387578 | perfluorohexanesulfonic acid | decreases expression | ISO | Csrnp2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of CSRNP2 mRNA | CTD | PMID:37995155 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of CSRNP2 mRNA | CTD | PMID:32588087 | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of CSRNP2 mRNA | CTD | PMID:18037150 | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of CSRNP2 mRNA | CTD | PMID:19167446 | sodium arsenate | multiple interactions | ISO | Csrnp2 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA | CTD | PMID:34876320 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CSRNP2 mRNA | CTD | PMID:28595984 and PMID:34032870 | sodium arsenite | multiple interactions | ISO | Csrnp2 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CSRNP2 mRNA | CTD | PMID:34876320 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of CSRNP2 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of CSRNP2 mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | ISO | Csrnp2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CSRNP2 mRNA | CTD | PMID:34492290 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of CSRNP2 mRNA | CTD | PMID:28542535 | triptonide | increases expression | ISO | Csrnp2 (Mus musculus) | 6480464 | triptonide results in increased expression of CSRNP2 mRNA | CTD | PMID:33045310 | valproic acid | increases expression | ISO | Csrnp2 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of CSRNP2 mRNA | CTD | PMID:21427059 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CSRNP2 mRNA | CTD | PMID:25979313 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CSRNP2 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CSRNP2 mRNA | CTD | PMID:18593933 | |